BG Medicine's Q1 Revenues Fall on Lower Service Revenue
May 15, 2012
BG Medicine's Q1 Revenues Fall on Lower Service Revenue
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- BG Medicine Partners with Kindstar to Offer Galectin-3 Testing in China
October 24, 2012 / GenomeWeb Daily News - BG Medicine Fails to Meet Listing Requirement, Nasdaq Warns Firm
May 20, 2013 / GenomeWeb Daily News - BG Medicine Posts 85 Percent Jump in Q1 Revenues, Appoints New CEO
May 10, 2013 / ProteoMonitor - BG Reports 257 Percent Jump in Q3 Revenues, May Offer CardioScore Through CLIA Lab as LDT
November 16, 2012 / ProteoMonitor - BG Medicine Q3 Revenues Spike as Restructuring Aims to Ramp up Commercialization
November 13, 2012 / GenomeWeb Daily News